Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing

K. B. Douglas, D. C. Windels, J. Zhao, A. V. Gadeliya, H. Wu, K. M. Kaufman, J. B. Harley, J. Merrill, R. P. Kimberly, G. S. Alarcón, E. E. Brown, J. C. Edberg, R. Ramsey-Goldman, Michelle Petri, J. D. Reveille, L. M. Vilá, P. M. Gaffney, J. A. James, K. L. Moser, M. E. Alarcón-Riquelme & 8 others T. J. Vyse, G. S. Gilkeson, C. O. Jacob, J. T. Ziegler, C. D. Langefeld, D. Ulgiati, B. P. Tsao, S. A. Boackle

Research output: Contribution to journalArticle

Abstract

Genetic factors influence susceptibility to systemic lupus erythematosus (SLE). A recent family-based analysis in Caucasian and Chinese populations provided evidence for association of single-nucleotide polymorphisms (SNPs) in the complement receptor 2 (CR2/CD21) gene with SLE. Here we confirmed this result in a case-control analysis of an independent European-derived population including 2084 patients with SLE and 2853 healthy controls. A haplotype formed by the minor alleles of three CR2 SNPs (rs1048971, rs17615, rs4308977) showed significant association with decreased risk of SLE (30.4% in cases vs 32.6% in controls, P = 0.016, OR = 0.90 (0.82 - 0.98)). Two of these SNPs are in exon 10, directly 5′ of an alternatively spliced exon preferentially expressed in follicular dendritic cells (FDC), and the third is in the alternatively spliced exon. Effects of these SNPs and a fourth SNP in exon 11 (rs17616) on alternative splicing were evaluated. We found that the minor alleles of these SNPs decreased splicing efficiency of exon 11 both in vitro and ex vivo. These findings further implicate CR2 in the pathogenesis of SLE and suggest that CR2 variants alter the maintenance of tolerance and autoantibody production in the secondary lymphoid tissues where B cells and FDCs interact.

Original languageEnglish (US)
Pages (from-to)457-469
Number of pages13
JournalGenes and Immunity
Volume10
Issue number5
DOIs
StatePublished - 2009

Fingerprint

Complement 3d Receptors
Alternative Splicing
Systemic Lupus Erythematosus
Single Nucleotide Polymorphism
Exons
Alleles
Follicular Dendritic Cells
Lymphoid Tissue
Autoantibodies
Haplotypes
Population
B-Lymphocytes
Maintenance
Genes

ASJC Scopus subject areas

  • Genetics(clinical)
  • Immunology
  • Genetics

Cite this

Douglas, K. B., Windels, D. C., Zhao, J., Gadeliya, A. V., Wu, H., Kaufman, K. M., ... Boackle, S. A. (2009). Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes and Immunity, 10(5), 457-469. https://doi.org/10.1038/gene.2009.27

Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. / Douglas, K. B.; Windels, D. C.; Zhao, J.; Gadeliya, A. V.; Wu, H.; Kaufman, K. M.; Harley, J. B.; Merrill, J.; Kimberly, R. P.; Alarcón, G. S.; Brown, E. E.; Edberg, J. C.; Ramsey-Goldman, R.; Petri, Michelle; Reveille, J. D.; Vilá, L. M.; Gaffney, P. M.; James, J. A.; Moser, K. L.; Alarcón-Riquelme, M. E.; Vyse, T. J.; Gilkeson, G. S.; Jacob, C. O.; Ziegler, J. T.; Langefeld, C. D.; Ulgiati, D.; Tsao, B. P.; Boackle, S. A.

In: Genes and Immunity, Vol. 10, No. 5, 2009, p. 457-469.

Research output: Contribution to journalArticle

Douglas, KB, Windels, DC, Zhao, J, Gadeliya, AV, Wu, H, Kaufman, KM, Harley, JB, Merrill, J, Kimberly, RP, Alarcón, GS, Brown, EE, Edberg, JC, Ramsey-Goldman, R, Petri, M, Reveille, JD, Vilá, LM, Gaffney, PM, James, JA, Moser, KL, Alarcón-Riquelme, ME, Vyse, TJ, Gilkeson, GS, Jacob, CO, Ziegler, JT, Langefeld, CD, Ulgiati, D, Tsao, BP & Boackle, SA 2009, 'Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing', Genes and Immunity, vol. 10, no. 5, pp. 457-469. https://doi.org/10.1038/gene.2009.27
Douglas, K. B. ; Windels, D. C. ; Zhao, J. ; Gadeliya, A. V. ; Wu, H. ; Kaufman, K. M. ; Harley, J. B. ; Merrill, J. ; Kimberly, R. P. ; Alarcón, G. S. ; Brown, E. E. ; Edberg, J. C. ; Ramsey-Goldman, R. ; Petri, Michelle ; Reveille, J. D. ; Vilá, L. M. ; Gaffney, P. M. ; James, J. A. ; Moser, K. L. ; Alarcón-Riquelme, M. E. ; Vyse, T. J. ; Gilkeson, G. S. ; Jacob, C. O. ; Ziegler, J. T. ; Langefeld, C. D. ; Ulgiati, D. ; Tsao, B. P. ; Boackle, S. A. / Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. In: Genes and Immunity. 2009 ; Vol. 10, No. 5. pp. 457-469.
@article{690e30cd5efd45ee96bf8781a4b3338f,
title = "Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing",
abstract = "Genetic factors influence susceptibility to systemic lupus erythematosus (SLE). A recent family-based analysis in Caucasian and Chinese populations provided evidence for association of single-nucleotide polymorphisms (SNPs) in the complement receptor 2 (CR2/CD21) gene with SLE. Here we confirmed this result in a case-control analysis of an independent European-derived population including 2084 patients with SLE and 2853 healthy controls. A haplotype formed by the minor alleles of three CR2 SNPs (rs1048971, rs17615, rs4308977) showed significant association with decreased risk of SLE (30.4{\%} in cases vs 32.6{\%} in controls, P = 0.016, OR = 0.90 (0.82 - 0.98)). Two of these SNPs are in exon 10, directly 5′ of an alternatively spliced exon preferentially expressed in follicular dendritic cells (FDC), and the third is in the alternatively spliced exon. Effects of these SNPs and a fourth SNP in exon 11 (rs17616) on alternative splicing were evaluated. We found that the minor alleles of these SNPs decreased splicing efficiency of exon 11 both in vitro and ex vivo. These findings further implicate CR2 in the pathogenesis of SLE and suggest that CR2 variants alter the maintenance of tolerance and autoantibody production in the secondary lymphoid tissues where B cells and FDCs interact.",
author = "Douglas, {K. B.} and Windels, {D. C.} and J. Zhao and Gadeliya, {A. V.} and H. Wu and Kaufman, {K. M.} and Harley, {J. B.} and J. Merrill and Kimberly, {R. P.} and Alarc{\'o}n, {G. S.} and Brown, {E. E.} and Edberg, {J. C.} and R. Ramsey-Goldman and Michelle Petri and Reveille, {J. D.} and Vil{\'a}, {L. M.} and Gaffney, {P. M.} and James, {J. A.} and Moser, {K. L.} and Alarc{\'o}n-Riquelme, {M. E.} and Vyse, {T. J.} and Gilkeson, {G. S.} and Jacob, {C. O.} and Ziegler, {J. T.} and Langefeld, {C. D.} and D. Ulgiati and Tsao, {B. P.} and Boackle, {S. A.}",
year = "2009",
doi = "10.1038/gene.2009.27",
language = "English (US)",
volume = "10",
pages = "457--469",
journal = "Genes and Immunity",
issn = "1466-4879",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing

AU - Douglas, K. B.

AU - Windels, D. C.

AU - Zhao, J.

AU - Gadeliya, A. V.

AU - Wu, H.

AU - Kaufman, K. M.

AU - Harley, J. B.

AU - Merrill, J.

AU - Kimberly, R. P.

AU - Alarcón, G. S.

AU - Brown, E. E.

AU - Edberg, J. C.

AU - Ramsey-Goldman, R.

AU - Petri, Michelle

AU - Reveille, J. D.

AU - Vilá, L. M.

AU - Gaffney, P. M.

AU - James, J. A.

AU - Moser, K. L.

AU - Alarcón-Riquelme, M. E.

AU - Vyse, T. J.

AU - Gilkeson, G. S.

AU - Jacob, C. O.

AU - Ziegler, J. T.

AU - Langefeld, C. D.

AU - Ulgiati, D.

AU - Tsao, B. P.

AU - Boackle, S. A.

PY - 2009

Y1 - 2009

N2 - Genetic factors influence susceptibility to systemic lupus erythematosus (SLE). A recent family-based analysis in Caucasian and Chinese populations provided evidence for association of single-nucleotide polymorphisms (SNPs) in the complement receptor 2 (CR2/CD21) gene with SLE. Here we confirmed this result in a case-control analysis of an independent European-derived population including 2084 patients with SLE and 2853 healthy controls. A haplotype formed by the minor alleles of three CR2 SNPs (rs1048971, rs17615, rs4308977) showed significant association with decreased risk of SLE (30.4% in cases vs 32.6% in controls, P = 0.016, OR = 0.90 (0.82 - 0.98)). Two of these SNPs are in exon 10, directly 5′ of an alternatively spliced exon preferentially expressed in follicular dendritic cells (FDC), and the third is in the alternatively spliced exon. Effects of these SNPs and a fourth SNP in exon 11 (rs17616) on alternative splicing were evaluated. We found that the minor alleles of these SNPs decreased splicing efficiency of exon 11 both in vitro and ex vivo. These findings further implicate CR2 in the pathogenesis of SLE and suggest that CR2 variants alter the maintenance of tolerance and autoantibody production in the secondary lymphoid tissues where B cells and FDCs interact.

AB - Genetic factors influence susceptibility to systemic lupus erythematosus (SLE). A recent family-based analysis in Caucasian and Chinese populations provided evidence for association of single-nucleotide polymorphisms (SNPs) in the complement receptor 2 (CR2/CD21) gene with SLE. Here we confirmed this result in a case-control analysis of an independent European-derived population including 2084 patients with SLE and 2853 healthy controls. A haplotype formed by the minor alleles of three CR2 SNPs (rs1048971, rs17615, rs4308977) showed significant association with decreased risk of SLE (30.4% in cases vs 32.6% in controls, P = 0.016, OR = 0.90 (0.82 - 0.98)). Two of these SNPs are in exon 10, directly 5′ of an alternatively spliced exon preferentially expressed in follicular dendritic cells (FDC), and the third is in the alternatively spliced exon. Effects of these SNPs and a fourth SNP in exon 11 (rs17616) on alternative splicing were evaluated. We found that the minor alleles of these SNPs decreased splicing efficiency of exon 11 both in vitro and ex vivo. These findings further implicate CR2 in the pathogenesis of SLE and suggest that CR2 variants alter the maintenance of tolerance and autoantibody production in the secondary lymphoid tissues where B cells and FDCs interact.

UR - http://www.scopus.com/inward/record.url?scp=67849133217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67849133217&partnerID=8YFLogxK

U2 - 10.1038/gene.2009.27

DO - 10.1038/gene.2009.27

M3 - Article

VL - 10

SP - 457

EP - 469

JO - Genes and Immunity

JF - Genes and Immunity

SN - 1466-4879

IS - 5

ER -